Product Specifications
Below are the key product attributes and specifications that provide detailed information about this item:
Product Overview
Glaxo Consumer Products presents Nicoderm CQ, a trusted stop-smoking aid designed to help you quit smoking gradually. The 21 mg strength transdermal patch delivers a controlled dose of nicotine to reduce withdrawal symptoms and cravings, making it easier to transition to a smoke-free life.
Features:
- Step-down nicotine therapy to gradually wean off dependence
- 21 mg strength for heavy smokers (those who smoke 10+ cigarettes per day)
- Transdermal patch for continuous, steady nicotine release over 24 hours
- Discreet and easy to use—simply apply to clean, dry skin
- Clinically proven to double the chances of quitting successfully
Specifications:
- Active Ingredient: Nicotine (21 mg per patch)
- Patch Size: Standard transdermal patch for comfortable wear
- Duration: One patch per day (24-hour wear)
- Recommended Treatment: 6 weeks (Step 1: 21 mg for weeks 1-4, then taper dosage)
Use Suggestion:
Apply the Nicoderm CQ patch to a clean, dry, hairless area of skin (upper arm, chest, or hip) upon waking. Rotate application sites daily to avoid irritation. Avoid using other nicotine products while wearing the patch. For best results, combine with a structured quit plan and behavioral support.
